News
News
PublISHED ON
UpDATED ON
Research funding available for next-generation biologics
The Swedish Research Council and Vinnova have formulated a national programme for protein research, method development and production of biologics. It is now possible to apply for up to 10 million SEK for protein research and process development for biologics. The call closes January 15, 2019.
The programme is a part of the government’s strategic investment in life science aiming to promote better health, face societal challenges, strengthen Sweden’s position as a leading country for research and development, and increase Sweden’s competitiveness in an international perspective.
The programme contains both protein research for biologics, as well as development of more efficient methods for next-generation production of biologics. The programme runs from 2016 to 2023 and comprises 320 million SEK in total.
A call for protein research and process development for biologics is now open and closes January 15, 2019.
You can find all the information (in Swedish) about the call on Vinnova’s website External link..
MORE WITHIN THE SAME SUBJECT AREA
-
News |
Published 23 February 2024
As from 2022, all clinical studies funded by the Swedish Research Council shall be registered in a public database. A recent follow-up shows that the majority of the clinical studies awarded funding in 2022 have been registered.
-
News |
Published 19 December 2023
The Swedish Research Council and Forte have mapped research in women’s health and diseases. The result is presented in a new report. The report points out knowledge needs linked to women’s health and diseases, and what research initiatives are needed...
-
Grant decision |
Published 8 December 2023
The Swedish Research Council has decided on the applications to be awarded Research project grant for international research collaboration within rare diseases (EJP RD) 2023. Our total grant amount for 2023–2026 is more than 20 million SEK.